Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression

A large body of clinical and nonclinical evidence supports the role of neurotoxic soluble beta amyloid (amyloid, Aβ) oligomers as upstream pathogenic drivers of Alzheimer’s disease (AD). Recent late-stage trials in AD that have evaluated agents targeting distinct species of Aβ provide compelling evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolar, Martin, Hey, John, Power, Aidan, Abushakra, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231952/
https://www.ncbi.nlm.nih.gov/pubmed/34198582
http://dx.doi.org/10.3390/ijms22126355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231952/
https://www.ncbi.nlm.nih.gov/pubmed/34198582
http://dx.doi.org/10.3390/ijms22126355

Ejemplares similares